Webinar
Optimizing Channel Strategy to Overcome CGT-Specific Barriers
Watch as Melissa Lattanzi, Vice President of Emerging Therapies at Cencora, shares her expertise in optimizing channel strategy for Cell and Gene Therapies (CGTs).
Key Insights
In this session, Lattanzi addresses fundamental questions and best practices for building a robust channel strategy designed to navigate the unique challenges faced by CGT companies.
- Understanding patient pathways: This presentation emphasizes the importance of knowing where and how patients are currently being treated. Identifying the specialties involved and the existing therapeutic landscape is crucial for developing an effective channel strategy.
- Navigating logistical challenges: The discussion highlights the specialized storage needs for CGT products, such as maintaining appropriate temperatures for gene and cell therapies, and explains the importance of coordination among patients, manufacturers, and treatment facilities to ensure timely product administration.
- Clinical and business considerations: The complexities of administering CGT therapies, including adverse event management and reimbursement challenges, are explored. This session also provides insights into how to structure partnerships and payment terms that alleviate financial risks for treatment centers.
Watch the full recording to gain an in-depth understanding of optimizing channel strategy in the CGT landscape. Discover how to effectively navigate the challenges and unlock opportunities in the transformative world of cell and gene therapy.
Pardot Form
